ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
120.767,19
-1,73%
S&P 500
5.346,99
-0,11%
US Dollar vs BRL
5,29355
-0,98%
Bitcoin
69.417,23
0,12%
Brent Oil
79,395
0,00%
Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Syndax Pharmaceuticals Inc (SNDX)

  7. Syndax Pharmaceuticals Inc (SNDX) Notícias

SNDX Syndax Pharmaceuticals Inc

19,50
0,10 (0,52%)
07 Jun 2024 - Fechado
Atrasado em 15 minutos
Nome da Ação Código da Ação Bolsa de Valores Tipo de Ativo
Syndax Pharmaceuticals Inc SNDX NASDAQ Ordinária
  Variação do Dia (p) Variação do Dia % Último Preço Hora
Upgrade Icon
0,10 0,52% 19,50 20:43:24
Preço de Abertura Preço Mínimo Preço Máximo Fech. Hoje Fech. Anterior
19,15 18,82 19,67 19,50 19,40
mais cotações »

Notícias Recentes

Data Hora Fonte Título
06/06/202408:00PRNUSSyndax Announces Plans to Advance into Phase 1b Portion of..
05/06/202408:00PRNUSSyndax Announces Participation at the Goldman Sachs 45th..
03/06/202417:05PRNUSSyndax Pharmaceuticals Reports Inducement Grants Under..
15/05/202417:05PRNUSSyndax Pharmaceuticals Appoints Aleksandra Rizo, M.D., Ph.D...
09/05/202408:00PRNUSSyndax Announces Participation at the Bank of America..
08/05/202408:06PRNUSSyndax Pharmaceuticals Reports First Quarter 2024 Financial..
03/05/202417:05PRNUSSyndax Pharmaceuticals Reports Inducement Grants Under..
01/05/202408:00PRNUSSyndax to Announce First Quarter 2024 Financial Results and..
10/04/202417:05PRNUSSyndax Announces Participation at the Stifel 2024 Virtual..
08/04/202408:00PRNUSSyndax Presents Positive Pediatric Data from Pivotal..
05/04/202417:05PRNUSSyndax Pharmaceuticals Reports Inducement Grants Under..
28/03/202408:00PRNUSSyndax Announces Completion of Enrollment in AUGMENT-101..
26/03/202417:05PRNUSSyndax Announces FDA Priority Review of NDA for Revumenib..
18/03/202408:00PRNUSSyndax Announces Appointment of Steven Closter as Chief..
01/03/202418:05PRNUSSyndax Pharmaceuticals Reports Inducement Grants Under..
27/02/202418:05PRNUSSyndax Pharmaceuticals Reports Fourth Quarter and Full Year..
26/02/202409:00PRNUSSyndax Announces Participation at Two Upcoming Investor..
20/02/202418:05PRNUSSyndax to Announce Fourth Quarter and Year-end 2023..
02/02/202418:05PRNUSSyndax Pharmaceuticals Reports Inducement Grants Under..
01/02/202418:10PRNUSSyndax Announces Participation at Two Upcoming Investor..
05/01/202418:05PRNUSSyndax Pharmaceuticals Reports Inducement Grants Under..
02/01/202418:05PRNUSSyndax Announces Presentation at 42nd Annual J.P. Morgan..
02/01/202409:00PRNUSSyndax Highlights Recent Updates and Anticipated 2024..
19/12/202318:16PRNUSSyndax Announces Closing of Public Offering of Common Stock..
15/12/202301:07PRNUSSyndax Announces Pricing of $200 Million Public Offering of..
14/12/202318:00PRNUSSyndax Announces Proposed $150 Million Public Offering of..
12/12/202314:00PRNUSSyndax Presents Positive Data from Pivotal AUGMENT-101 Trial..
11/12/202309:30PRNUSSyndax Announces Positive Data for Revumenib in Patients..
11/12/202308:33BWIncyte und Syndax präsentieren bei ASH-Plenarsitzung weitere..
10/12/202319:00BWIncyte and Syndax Present Additional Data from Positive..
04/12/202309:00PRNUSSyndax to Host Investor Event to Discuss Axatilimab and..
01/12/202318:05PRNUSSyndax Pharmaceuticals Reports Inducement Grants Under..
21/11/202311:00PRNUSSyndax Announces Data from Pivotal AUGMENT-101 Trial of..
07/11/202309:00PRNUSSyndax Announces Participation at Stifel Healthcare..
03/11/202317:05PRNUSSyndax Pharmaceuticals Reports Inducement Grants Under..
02/11/202317:05PRNUSSyndax Pharmaceuticals Reports Third Quarter 2023 Financial..
02/11/202310:00PRNUSSyndax Announces Updated Data Supporting Impressive Clinical..
26/10/202308:00PRNUSSyndax to Announce Third Quarter 2023 Financial Results and..
24/10/202308:00PRNUSSyndax to Initiate NDA Submission of Revumenib in..
06/10/202317:05PRNUSSyndax Pharmaceuticals Reports Inducement Grants Under..
02/10/202308:00PRNUSSyndax Announces Pivotal AUGMENT-101 Trial of Revumenib in..
29/09/202317:05PRNUSSyndax to Announce Topline Results from Pivotal AUGMENT-101..
01/09/202317:05PRNUSSyndax Pharmaceuticals Reports Inducement Grants Under..
31/08/202317:05PRNUSSyndax Announces Participation at the Citi 18th Annual..
04/08/202317:05PRNUSSyndax Pharmaceuticals Reports Inducement Grants Under..
03/08/202317:05PRNUSSyndax Pharmaceuticals Reports Second Quarter 2023 Financial..
25/07/202308:00PRNUSSyndax to Announce Second Quarter 2023 Financial Results and..
24/07/202308:00PRNUSSyndax and Incyte Announce Positive Topline Results from the..
07/07/202317:13PRNUSSyndax Pharmaceuticals Reports Inducement Grants Under..

Seu Histórico Recente

NASDAQ
SNDX
Syndax Pharmaceuticals
BIT
F16792
Vontobel Financial Produ...
NASDAQ
AAXFDXX
Ubs Ag London Branch Iss...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados